Selenium
Adenomatous Colorectal Polyps
University of ArizonaSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Adenomatous Colorectal Polyps cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Docosahexaenoic Acid Vanderbilt University | Phase 2 | B |
Eicosapentanoic Acid Vanderbilt University | Phase 2 | B |
Acetylsalicylic Acid University of Calgary | Phase 2 | CCC |
TRIBENOSIDE Lewai Sharki Abdulaziz, MSc PhD | Early Phase 1 | CC |
CARTIA Lewai Sharki Abdulaziz, MSc PhD | Early Phase 1 | CC |
LIDOCAINE Lewai Sharki Abdulaziz, MSc PhD | Early Phase 1 | CC |
Glyceryl Trinitrate Lewai Sharki Abdulaziz, MSc PhD | Early Phase 1 | CC |
Dordaviprone National Cancer Institute (NCI) | Phase 1 | C |
Same molecule, other indications
Selenium is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →